Related Experiment Video
Updated: Aug 2, 2025

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
The Challenge of Emerging Resistant Gram-Positive Pathogens in Hip and Knee Periprosthetic Joint Infections
Kevin L Garvin1, Beau J Kildow1, Angela L Hewlett2
1Department of Orthopaedic Surgery and Rehabilitation, University of Nebraska Medical Center, Omaha, Nebraska.
Abstract:
➤ An increase in resistant bacterial pathogens has occurred over the last 4 decades.➤ Careful patient selection and improving or correcting risk factors for periprosthetic joint infection (PJI) before elective surgical treatment are strongly recommended. ➤ Appropriate microbiological methods, including those used to detect and grow Cutibacterium acnes, are recommended. ➤ Antimicrobial agents used in the prevention or management of infection should be selected appropriately and the duration of therapy should be carefully considered in order to mitigate the risk of developing bacterial resistance.➤ Molecular methods including rapid polymerase chain reaction (PCR) diagnostics, 16S sequencing, and/or shotgun and/or targeted whole-genome sequencing are recommended in culture-negative cases of PJI.➤ Expert consultation with an infectious diseases specialist (if available) is recommended to assist with the appropriate antimicrobial management and monitoring of patients with PJI.
Insights
Rising bacterial resistance necessitates careful patient selection and optimized antimicrobial strategies for periprosthetic joint infections (PJI). Advanced molecular diagnostics and infectious disease consultation are key for effective management and preventing further resistance.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Microbiology
Background:
- Increasing prevalence of antibiotic-resistant bacterial pathogens over the past four decades.
- Periprosthetic joint infection (PJI) poses a significant challenge in orthopedic surgery.
- The need for optimized diagnostic and therapeutic strategies to combat resistant infections.
Purpose of the Study:
- To provide recommendations for the prevention and management of periprosthetic joint infections (PJI).
- To address the growing issue of bacterial resistance in the context of orthopedic procedures.
- To highlight the importance of appropriate microbiological techniques and antimicrobial stewardship.
Main Methods:
- Review of current literature and guidelines on PJI prevention and treatment.
- Emphasis on careful patient selection and risk factor modification prior to elective surgery.
- Recommendation of specific microbiological methods, including those for Cutibacterium acnes detection.
Main Results:
- Advocates for appropriate selection and judicious duration of antimicrobial agents to prevent resistance.
- Recommends molecular diagnostic methods (PCR, 16S sequencing, whole-genome sequencing) for culture-negative PJI cases.
- Stresses the value of infectious disease specialist consultation for optimal patient management.
Conclusions:
- Proactive measures, including patient optimization and precise microbiological diagnosis, are crucial for PJI management.
- Antimicrobial stewardship and advanced molecular diagnostics are essential to combat resistant pathogens.
- Multidisciplinary collaboration, including infectious disease specialists, improves outcomes in PJI patients.
Related Concept Videos
Development of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis I: Introduction
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Endocarditis III: Medical Management

